Jonathan M Taljonick, PT, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1235 S Center Rd Ste 12, Burton, MI 48509 Phone: 800-974-4378 Fax: 630-515-1536 |
Aaron Trevarrow, LPTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1235 S Center Rd Ste 12, Burton, MI 48509 Phone: 810-743-8820 |
News Archive
"The rotavirus vaccine introduced in Mexico in 2007 still appears to be preventing diarrhea-related deaths in children, despite speculation that years later the vaccine may not be as effective," according to the Los Angeles Times' "Booster Shots" blog.
Cancer researchers at the University of Bath have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers. The molecules could eventually be developed into new anti-cancer drugs.
Pfizer Inc. announced today that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to develop and commercialize generic medicines.
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
Mpex Pharmaceuticals, Inc. today announced positive data from its Phase 2b clinical trial with Aeroquin((R)) (a novel aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF). Trial results showed that nebulized Aeroquin met the primary endpoint of reducing bacterial counts of Pseudomonas aeruginosa (P. aeruginosa) in sputum after 28 days of dosing versus placebo.
› Verified 1 days ago